SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 328 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,415,149 | -40.8% | 61,171 | -44.0% | 0.08% | -31.7% |
| Q2 2023 | $12,519,326 | -60.4% | 109,320 | -52.3% | 0.12% | -63.3% |
| Q1 2023 | $31,582,780 | -6.9% | 229,143 | -12.4% | 0.33% | -11.4% |
| Q4 2022 | $33,910,827 | +8.0% | 261,698 | -7.8% | 0.37% | +0.3% |
| Q3 2022 | $31,388,000 | -6.5% | 283,950 | -36.6% | 0.37% | -4.9% |
| Q2 2022 | $33,588,000 | -13.0% | 448,080 | -9.3% | 0.39% | +10.9% |
| Q1 2022 | $38,591,000 | -22.7% | 493,996 | -10.9% | 0.35% | -11.6% |
| Q4 2021 | $49,917,000 | -14.7% | 554,323 | -12.4% | 0.40% | -14.1% |
| Q3 2021 | $58,510,000 | +22.3% | 632,679 | +2.8% | 0.46% | +31.1% |
| Q2 2021 | $47,855,000 | +182.5% | 615,580 | +169.2% | 0.35% | +185.4% |
| Q1 2018 | $16,940,000 | – | 228,640 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |